Trial Profile
Effects of Shifting From Twice Daily Insulin Glargine or Detemir to Once Daily Insulin Degludec in Type 1 Diabetic Patients. An Observational Study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Aug 2017
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary) ; Insulin detemir; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Basal21
- 14 Aug 2016 Status changed from recruiting to completed.
- 17 Feb 2015 New trial record